Our Board is Highly Committed & Engaged in our Mission & Vision

Ms. Dawn Svoronos (Graham) is an international commercial executive with a proven track record of expanding both revenue and the footprint of new technologies across multiple therapeutic areas while providing strategic leadership and guidance. 

Ms. Svoronos concluded her twenty-three year commercial career with Merck & Co. Inc. as President of Europe & Canada, a region comprised of thirty-seven EU and EU accession countries and Canada. Prior to that role, Ms. Svoronos served as President of Merck in Canada and Vice-President of Asia Pacific and as the Global Franchise leader for Merck brands in osteoporosis, arthritis and analgesics. Ms. Svoronos serves as an advisor to a number of organizations in the bio-sciences industry and currently serves on the Boards of Directors of five publicly-trades companies: PTC Therapeutics in New Jersey, Theratechnologies in Montreal, Quebec, Canada, Xenon Pharmaceuticals in Vancouver, British Columbia, Canada, Global Blood Therapeutics in California and Adverum Biotechnologies, also in California.